Tissue polypeptide antigen (TPA) in pancreatic cancer diagnosis.
Main Authors: | Panucci, A., Fabris, C., Del Favero, G., Basso, D., Marchioro, L., Piccoli, A., Burlina, A., Naccarato, R. |
---|---|
Format: | Online |
Language: | English |
Published: |
1985
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977229/ |
Similar Items
-
A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.
by: Pasanen, P. A., et al.
Published: (1994) -
Serum DU-PAN-2 in the differential diagnosis of pancreatic cancer: influence of jaundice and liver dysfunction.
by: Fabris, C., et al.
Published: (1991) -
Measurements of tissue polypeptide-specific antigen and prostate-specific antigen in prostate cancer patients under intermittent androgen suppression therapy.
by: Theyer, G., et al.
Published: (1997) -
Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer.
by: Carpelan-Holmström, M., et al.
Published: (1996) -
Diagnostic value of tissue polypeptide-specific antigen (TPS) in neuroblastoma and Wilms' tumour.
by: Rebhandl, W., et al.
Published: (1998)